The newly published report by IMARC Group has recently released a report titled “Delirium Market: Analysis of Epidemiology, Industry Trends, Size, Share, and Future Forecast (2023-2033)” that presents a comprehensive assessment of the delirium market. The report provides an extensive overview of the latest market trends, growth prospects, investment opportunities, and industry outlook, as well as an in-depth analysis of the disease landscape, market size, and growth trends. Furthermore, the report offers an analysis of competitors, regional markets, and recent advancements in the global market. It also sheds light on crucial segments and market drivers, along with challenges faced by industry players. This report is a valuable resource for stakeholders who want to gain valuable insights into the delirium market.
Delirium refers to a sudden and severe impairment of mental function that causes confused thinking and reduced awareness of surroundings. Some of the common symptoms of the disease are the inability to focus or concentrate, impaired memory, difficulty processing information, and hallucinations or delusions. Various other indications of delirium include agitation, altered appetite, anxiety, restlessness, sleep disturbances, etc. The diagnosis of delirium is mainly based on a clinical assessment of the patient’s symptoms and cognitive function, as well as an examination of their medical history and medications. Additionally, several blood, urine, and brain imaging tests are also performed to rule out any underlying issues among patients.
Request a Free Sample Report: https://www.imarcgroup.com/delirium-market/requestsample
Market Trend:
The elevating prevalence of neurological disorders, on account of various associated triggering factors, including nerve injuries, genetic defects, congenital abnormalities, etc., is primarily augmenting the delirium market. In addition to this, the growing adoption of medications like antipsychotics and benzodiazepines for managing the symptoms of delirium, such as agitation, hallucinations, delusions, etc., is propelling the market growth. Furthermore, the increasing usage of cognitive testing, including the mini-mental state examination (MMSE), as part of the delirium diagnosis to assess baseline cognitive function and detect changes associated with the ailment is acting as another significant growth-inducing factor.
Apart from this, several key players are heavily investing in understanding the underlying mechanisms of delirium, such as modifications in brain function and the role of inflammation, in identifying new approaches to the prevention and treatment of the disease, which is positively influencing the market growth. Moreover, the emerging popularity of standardized assessment tools, including the confusion assessment method (CAM) and the delirium observation screening scale (DOSS), which enable non-psychiatrically trained clinicians to identify and diagnose the ailment, is projected to fuel the delirium market in the coming years.
Report Period:
- Base Year: 2022
- Historical Period: 2017-2022
- Market Forecast: 2023-2033
Countries Included:
- United States
- Germany
- France
- United Kingdom
- Italy
- Spain
- Japan
Analysis Covered Across Each Country
- Historical, current, and future epidemiology scenario
- Historical, current, and future performance of the delirium market
- Historical, current, and future performance of various therapeutic categories in the market
- Sales of various drugs across the delirium market
- Reimbursement scenario in the market
- In-market and pipeline drugs
In-Market Drugs
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Drug Uptake and Market Performance
Late-Stage Pipeline Drugs
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Regulatory Status
Ask an Analyst for Report Customization with TOC List of figures: https://bit.ly/3qhHoS1
Key Questions Answered in this Report:
- How has the delirium market performed so far and how will it perform in the coming years?
- What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
- What was the country-wise size of the delirium market across the seven major markets in 2022 and what will it look like in 2033?
- What is the growth rate of the delirium market across the seven major markets and what will be the expected growth over the next ten years?
- What are the key unmet needs in the market?
About Us: –
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
